Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations), Thyrocare Technologies has informed that Nitin Chugh, Chief Commercial Officer and part of the Senior Management Personnel of Thyrocare Technologies have decided to pursue an opportunity outside the organization. He was appointed as Chief Commercial Officer of the Company, forming part of its Senior Management, with effect from February 1, 2024, and will complete his handover and cease to be associated with the Company with effect from the close of business hours on November 30, 2025. The Company has substantially progressed the process of identifying a suitable replacement for the said position. The details will be intimated to the Stock Exchanges in due course, in compliance with applicable laws. In compliance with Regulation 30 of the SEBI LODR Regulations and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, the requisite disclosure is enclosed as Annexure–1. The resignation letter submitted by Nitin Chugh is enclosed as Annexure-2.
The above information is a part of company’s filings submitted to BSE.
